Brian Ostrander

Brian Ostrander is an accomplished clinical operations leader with extensive experience in the biotechnology and pharmaceutical industries. As the Vice President of Clinical Operations at NiKang Therapeutics Inc. since February 2025, Brian oversees the development of innovative small molecule drugs for unmet medical needs. Prior to this role, Brian served as Vice President and Head of Clinical Operations at OncoNano Medicine, Inc., and held various positions at INSIGHTEC, including Regional Director of Clinical Affairs in Europe. Brian's background includes independent consulting for clinical development phases, project management at Reata Pharmaceuticals, and clinical research roles at Amgen, PPD, and MedTrials. Brian holds a Master of Science in Biology from the University of the Incarnate Word and a Bachelor of Science in Entomology from Texas A&M University.